FDA informs gene-drug associations, and Quest Diagnostics uses Coriell Life Sciences for personalized reports.
1 report, 1 independent
Updated Sep 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA informs gene-drug associations, and Quest Diagnostics uses Coriell Life Sciences for personalized reports.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Quest Diagnostics
medical research company
Related events
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- FDA provided guidance for HCW Biologics' IND application.
- A company involving Oxford seeks FDA clearance for a new diagnostic test.
- Zenith collaborates with Harvard researchers on clinical studies, receiving FDA clearance for the trial.
- Arthur Caplan questioned the FDA regarding the status of clinical trials in 2006.
Coverage
Newest first; wire copies grouped- Medical Device NetworkQuest Diagnostics introduces new pharmacogenomic testing service Quest Diagnostics has introduced a new pharmacogenomic (PGx) laboratory testing service designed to assist healthcare providers in und